Znaczenie dopaminy w regulacji stanów snu i czuwania

• Authors: Jolanta Orzeł-Gryglewska

Title variants

EN

The role of dopamine in the control of sleep-wake states

• Languages of publication: PL EN

Abstracts

PL

Sen i czuwanie regulowane są przez szereg neurotransmiterów i neuromodulatorów ośrodkowego układu nerwowego. W pracy przedstawiono fakty przemawiające za udziałem dopaminergicznego układu mezostriatalnego i mezokortykolimbicznego w regulacji snu i czuwania. Omówiono wpływ dopaminy, jej agonistów i transportera dopaminowego na stan czuwania i snu, zaburzenia snu towarzyszące dysfunkcjom układu dopaminergicznego oraz rolę dopaminy w śnie REM i indukcji marzeń sennych. Przedstawiono także propozycję modelu uwzględniającego udział dróg mezolimbicznych w systemie generacji hipokampalnego rytmu theta, który jest jedną z kryterialnych cech snu REM.

EN

Sleep and wakefulness are regulated by a number of neurotransmitters and neuromodulators of the central nervous system. This paper presents the facts supporting the role of the dopaminergic mesocorticolimbic and mesostriatal systems in the regulation of sleep and wakefulness. The effects of dopamine, its agonists and dopamine transporter on wakefulness, sleep, sleep disorders and the role of dopamine in the induction of REM sleep and dreams are discussed. Mesolimbic pathways are included in a suggested model of generation of hippocampal theta rhythm, which is one of the criterial features of REM sleep.

• Journal: Kosmos
• Year: 2014
• Volume: 63
• Issue: 2
• Pages: 189-200

Dates

published

2014

Contributors

author

Jolanta Orzeł-Gryglewska

• Katedra Fizjologii Zwierząt i Człowieka, Wydział Biologii Uniwersytetu Gdańskiego, Wita Stwosza 59, 80-308 Gdańsk, Polska

References

• Berry R. B., 2012. Neurobiology of sleep. [W:] Fundamentals of sleep medicine. Berry R. B. (red.). Elsevier Saunders, Philadelphia, 91-100.
• Bland B. H., 1986. The physiology and pharmacology of hippocampal formation theta rhythms. Prog. Neurobiol. 26, 1-54.
• Cohrs S., 2008. Sleep disturbances in patients with schizophrenia: impact and effect of antipsychotics. CNS Drugs 22, 939-962.
• Dahan L., Astier B., Vautrelle N., Urbain N., Kocsis B., Chouvet G., 2007. Prominent burst firing of dopaminergic neurons in the ventral tegmental area during paradoxical sleep. Neuropsychopharmacology 32, 1232-1241.
• Demet E. M., Chicz-Demet A., Fallon J. H., Sokolski K. N., 1999. Sleep deprivation therapy in depressive illness and Parkinson's disease. Prog. Neuropsychopharmacol. Biol. Psych. 23, 753-784.
• Dymecki J., Lechowicz W., Bertrand E., Szpak G. M., 1996. Changes in dopaminergic neurons of the mesocorticolimbic system in Parkinson's disease. Folia Neuropathol. 34, 102-106.
• Dzirasa K., Ribeiro S., Costa R., Santos L. M., Lin S. C., Grosmark A., Sotnikova T. D., Gainetdinov R. R., Caron M. G., Nicolelis M. A., 2006. Dopaminergic control of sleep-wake states. J. Neurosci. 26, 10577-10589.
• Ferreira J. G. P., Del-Fava F., Hasue R. H., Shammah-Lagnado S. J., 2008. Organization of ventral tegmental area projections to the ventral tegmental area-nigral complex in the rat. Neuroscience 153, 196-213.
• Fifel K., Vezoli J., Dzahini K., Claustrat B., Leviel V., Kennedy H., Procyk E., Dkhissi-Benyahya O., Gronfier C., Cooper H. M., 2014. Alteration of daily and circadian rhythms following dopamine depletion in MPTP treated non-human primates. PLoS One 9(1):e86240. doi: 10.1371/journal.pone.
• Finan P. H., Smith M. T., 2013. The comorbidity of insomnia, chronic pain, and depression: Dopamine as a putative mechanism. Sleep Med. Rev. 17, 173-183.
• Fitch T. E., Sahr R. N., Eastwood B. J., Zhou F. C., Yang C. R., 2006. Dopamine D1/5 receptor modulation of firing rate and bidirectional theta burst firing in medial septal/vertical limb of diagonal band neurons in vivo. J. Neurophysiol. 95, 2808-2820.
• Flores J. A., El Banoua F., Galán-Rodríguez B., Fernandez-Espejo E., 2004. Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. Pain 110, 205-214.
• Garcia-Borreguero D., Larrosa O., Bravo M., 2003. Parkinson's disease and sleep. Sleep Med. Rev. 7, 115-129.
• Geisler S., Zahm D. S., 2005. Afferents of the ventral tegmental area in the rat-anatomical substratum for integrative functions. J. Comp. Neurol. 490, 270-294.
• González S., Moreno-Delgado D., Moreno E., Pérez-Capote K., Franco R., Mallol J., Cortés A., Casadó V., Lluís C., Ortiz J., Ferré S., Canela E., McCormick P. J., 2012. Circadian-related heteromerization of adrenergic and dopamine D receptors modulates melatonin synthesis and release in the pineal gland. PLoS Biol. 10(6):e1001347. doi: 10.1371/journal.pbio.1001347.
• Gottesmann C., 1999. Neurophysiological support of consciousness during waking and sleep. Prog. Neurobiol. 59, 469-508.
• Hasselmo M. E., 2005. What is the function of hippocampal theta rhythm? Linking behavioral data to phasic properties of field potential and unit recording data. Hippocampus 15, 936-949.
• Holst S. C., Bersagliere A., Bachmann V., Berger W., Achermann P., Landolt H. P., 2014. Dopaminergic role in regulating neurophysiological markers of sleep homeostasis in humans. J. Neurosci. 34, 566-573.
• Iranzo A., 2011. Sleep-wake changes in the premotor stage of Parkinson disease. J. Neurol. Sci. 310, 283-285.
• Jones B. E., 2005. From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol. Sci. 26, 578-586.
• Jones B. E., 2011. Neurobiology of waking and sleeping. [W:] Handbook of Clinical Neurology. 98, Sleep Disorders, Part 1. Montagna P., Chokroverty S. (red.). Elsevier B.V., Londyn, 131-149.
• Konopacki J., Bland B. H., Roth S. H., 1988. Evidence that activation of in vitro hippocampal theta rhythm only involves muscarinic receptors. Brain Res. 455, 110-114.
• Kulisevsky J., Roldan E., 2004. Hallucinations and sleep disturbances in Parkinson's disease. Neurology 63, S28-30.
• Léger L., Sapin E., Goutagny R., Peyron C., Salvert D., Fort P., Luppi P. H., 2010. Dopaminergic neurons expressing Fos during waking and paradoxical sleep in the rat. J. Chem. Neuroanatom. 39, 262-271.
• Léna I., Parrot S., Deschaux O., Muffat-Joly S., Sauvinet V., Renaud B., Suaud-Chagny M. F., Gottesmann C., 2005. Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep-wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. J. Neurosci. Res. 81, 891-899.
• Lima M. M. S., Reksidler A. B., Vital M. A. B. F., 2008. The dopaminergic dilema: Sleep or wake? Implications in Parkinson's disease. Biosci. Hypoth. 1, 9-13.
• Luppi P. H., Clement O., Garcia S. V., Brischoux F., Fort P., 2013. New aspects in the pathophysiology of rapid eye movement sleep behavior disorder: the potential role of glutamate, gamma-aminobutyric acid, and glycine. Sleep Med. 14, 714-718.
• Maloney K. J., Mainville L., Jones B. E., 2002. c-Fos expression in dopaminergic and GABAergic neurons of the ventral mesencephalic tegmentum after paradoxical sleep deprivation and recovery. Eur. J. Neurosci. 15, 774-778.
• Monti J. M., Monti D., 2004. Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med. Rev. 8, 133-148.
• Monti J. M., Monti D., 2007. The involvement of dopamine in the modulation of sleep and waking. Sleep Med. Rev. 11, 113-133.
• Monti J. M., Bahammam A. S., Pandi-Perumal S. R., Bromundt V., Spence D. W., Cardinali D. P., Brown G. M., 2013. Sleep and circadian rhythm dysregulation in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 43, 209-216.
• Orzeł-Gryglewska J., Jurkowlaniec E., Trojniar W., 2006. Microinjection of procaine and electrolytic lesion in the ventral tegmental area suppressed hippocampal theta rhythm in urethane-anesthetized rats. Brain Res. Bull. 68, 295-309.
• Orzeł-Gryglewska J., Kuśmierczak M., Jurkowlaniec E., 2010. Involvement of GABAergic transmission in the midbrain ventral tegmental area in the regulation of hippocampal theta rhythm. Brain Res. Bull. 83, 310-320.
• Orzeł-Gryglewska J., Kuśmierczak M., Majkutewicz I., Jurkowlaniec E., 2012. Induction of hippocampal theta rhythm by electrical stimulation of the ventral tegmental area and its loss after septum inactivation. Brain Res. 1436, 51-67.
• Orzeł-Gryglewska J., Kuśmierczak M., Matulewicz P., Jurkowlaniec E., 2013. Dopaminergic transmission in the midbrain ventral tegmental area in the induction of hippocampal theta rhythm. Brain Res. 1510, 63-77.
• Orzeł-Gryglewska J., Matulewicz P., Jurkowlaniec E., 2014. Theta activity in local field potential of the ventral tegmental area in sleeping and waking rats. Behav. Brain Res. 265, 84-92.
• Pace-Schott E. F., Hobson J. A., 2002. The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat. Rev. Neurosci. 3, 591-605.
• Perogamvros L., Schwartz S., 2012. The roles of the reward system in sleep and dreaming. Neurosci. Biobehav. Rev. 36, 1934-1951.
• Rye D. B., 2004. Parkinson's disease and RLS: the dopaminergic bridge. Sleep Med. 5, 317-328.
• Smidt M. P., Burbach J. P. H., 2007. How to make a mesodiencephalic dopaminergic neuron. Nat. Rev. Neurosci. 8, 21-32.
• Solms M., 2000. Dreaming and REM sleep are controlled by different brain mechanisms. Behav. Brain Sci. 23, 843-850.
• Vertes R. P., 2005. Hippocampal theta rhythm: a tag for short-term memory. Hippocampus 15, 923-935.
• Wang H. L., Morales M. M., 2009. Pedunculopontine and laterodorsal tegmental nuclei contain independent populations of cholinergic, glutamatergic and GABAergic neurons in the rat. Eur. J. Neurosci. 29, 340-358.
• Wisor J. P., Nishino S., Sora I., Uhl G. H., Mignot E., Edgar D. M., 2001. Dopaminergic role in stimulant-induced wakefulness. J. Neurosci. 21, 1787-1794.